Zyversa TherapeuticsZVSA
13F holders, Q4 2024 (December 31)8holders +2
3new positions
2sold out
1famous investor
$1.06avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Zyversa Therapeutics Inc. (ZVSA) in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 2 sold out. The largest holders were Citigroup Inc. ($37K), Virtu Financial LLC ($27K) and Renaissance Technologies ($14K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Zyversa Therapeutics Inc.
- CUSIP
- 98987D300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $78K |
| Exits | 2 | $2 |
All 13F filers, Q3 2024 → Q4 2024: 78,027 shares bought and 53 shares sold, net +77,974 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Citigroup Inc. | 0.00% | New | 35,035 | $37K |
| Virtu Financial LLC | 0.00% | New | 25,259 | $27K |
| Renaissance Technologies | 0.00% | New | 12,961 | $14K |
| UBS Group AG | 0.00% | Add +867.0% | 4,187 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +35.7% | 3,483 | $4K |
| Bank of America Corp. | 0.00% | Add +1262.5% | 109 | $115 |
| SBI Securities Co., Ltd. | 0.00% | — | 50 | $53 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ZVSA's weight in each manager's 13F, not the share of Zyversa Therapeutics Inc. the manager owns.